M3 Inc
TSE:2413

Watchlist Manager
M3 Inc Logo
M3 Inc
TSE:2413
Watchlist
Price: 1 375.5 JPY Market Closed
Market Cap: 934.1B JPY
Have any thoughts about
M3 Inc?
Write Note

M3 Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

M3 Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
M3 Inc
TSE:2413
Other Long-Term Assets
ÂĄ14.3B
CAGR 3-Years
53%
CAGR 5-Years
21%
CAGR 10-Years
32%
EM Systems Co Ltd
TSE:4820
Other Long-Term Assets
ÂĄ1B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
5%
S
Software Service Inc
TSE:3733
Other Long-Term Assets
ÂĄ833.6m
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
20%
Medley Inc
TSE:4480
Other Long-Term Assets
ÂĄ1.2B
CAGR 3-Years
30%
CAGR 5-Years
35%
CAGR 10-Years
N/A
JMDC Inc
TSE:4483
Other Long-Term Assets
ÂĄ2.2B
CAGR 3-Years
8%
CAGR 5-Years
33%
CAGR 10-Years
N/A
e
eWeLL Co Ltd
TSE:5038
Other Long-Term Assets
ÂĄ134.9m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

M3 Inc
Glance View

Market Cap
934B JPY
Industry
Health Care

M3 Inc. emerged from Japan in the late 1990s, rapidly morphing from a novel digital venture into a formidable player in the global medical information services arena. The company's genesis was rooted in the transformative vision of leveraging web-based platforms to bridge vast distances between healthcare professionals, providing them with timely, accurate information and resources. As the internet began revolutionizing industries, M3 Inc. seized this opportunity, focusing on creating a seamless digital environment that connected pharmaceutical companies with medical professionals. Their flagship offering, M3.com, became a pivotal platform—essentially serving as a nexus where healthcare giants could introduce their latest products and innovations to an audience of medical practitioners, facilitating informed decision-making and nurturing vital industry relationships. Reaching beyond Japanese shores, M3 Inc. strategically expanded its influence into markets in Europe, the United States, and further afield, deftly tailoring its platforms to meet diverse regulatory standards and cultural nuances. Today, its financial vitality is driven by a multifaceted business model. Primarily, M3 derives revenue from pharmaceutical companies and medical device makers who pay for advertising space and market research insights on its network, valuing the direct engagement with physicians it facilitates. Moreover, the company has smartly diversified its portfolio by incorporating online healthcare services and physician recruitment, offering a comprehensive suite of services that cater to the evolving needs of the medical community. By aligning its growth with the digital evolution of the healthcare industry, M3 Inc. continues to solidify its role as a linchpin in the health information ecosystem.

Intrinsic Value
2 281.04 JPY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is M3 Inc's Other Long-Term Assets?
Other Long-Term Assets
14.3B JPY

Based on the financial report for Sep 30, 2024, M3 Inc's Other Long-Term Assets amounts to 14.3B JPY.

What is M3 Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
32%

Over the last year, the Other Long-Term Assets growth was 70%. The average annual Other Long-Term Assets growth rates for M3 Inc have been 53% over the past three years , 21% over the past five years , and 32% over the past ten years .

Back to Top